RA Capital Management’s Larimar Therapeutics LRMR Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-6,045,351	Closed	-$19.5M	–	80
2025 Q3	$19.5M	Hold	6,045,351	–	–	0.24%	43
2025 Q2	$17.5M	Hold	6,045,351	–	–	0.29%	36
2025 Q1	$13M	Hold	6,045,351	–	–	0.22%	59
2024 Q4	$23.4M	Hold	6,045,351	–	–	0.31%	54
2024 Q3	$39.6M	Hold	6,045,351	–	–	0.46%	43
2024 Q2	$43.8M	Hold	6,045,351	–	–	0.58%	43
2024 Q1	$45.9M	Buy	+6,045,351	New	+$47.1M	0.58%	43
2022 Q3	–	Sell	-1,031,482	Closed	-$2.02M	–	90
2022 Q2	$2.02M	Sell	1,031,482 -250,378	-20%	-$740K	0.05%	81
2022 Q1	$5.19M	Sell	1,281,860 -52,750	-4%	-$345K	0.11%	88
2021 Q4	$14.4M	Sell	1,334,610 -180,541	-12%	-$2.01M	0.25%	68
2021 Q3	$17.5M	Hold	1,515,151	–	–	0.24%	65
2021 Q2	$14.9M	Hold	1,515,151	–	–	0.24%	61
2021 Q1	$22.1M	Hold	1,515,151	–	–	0.33%	54
2020 Q4	$32.4M	Hold	1,515,151	–	–	0.45%	50
2020 Q3	$23M	Hold	1,515,151	–	–	0.42%	46
2020 Q2	$19.5M	Buy	+1,515,151	New	+$17.6M	0.38%	41
2015 Q2	–	Sell	-61,080	Closed	-$29M	–	63
2015 Q1	$29M	Hold	61,080	–	–	2.88%	12
2014 Q4	$22.6M	Hold	61,080	–	–	2.43%	13
2014 Q3	$14.4M	Buy	+61,080	New	+$13.8M	1.7%	18